AI assistant
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2025
Apr 4, 2025
35599_dirs_2025-04-03_0c7fe847-e177-475b-8a44-3001afb3b201.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2025-03-28
Reporting Person: Evans Terry L (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-28 | Restricted Share Unit | $0 | A | 10000 | Acquired | 2035-03-28 | Common Shares (10000) | Direct |
Footnotes
F1: On March 28, 2025,Terry Evans was awarded restricted share units to acquire 10,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan.
F2: One-third of the shares subject to this award shall be released from restriction as of March 28, 2026 (the "Vesting Commencement Date"). One twenty-fourth of the shares subject to this award may be released from restriction as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028 and thereafter, 100% of the total number of shares subject to this award shall be released from restriction.